Processa Pharmaceuticals Inc (PCSA)
1.07
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
1.07
0.00 (0.00%)
After-Hours: 20:00
Processa Pharmaceuticals Price: 1.07 for Nov. 13, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 13, 2024 | 1.08 | 1.15 | 1.045 | 1.07 | 18655.00 |
Nov 12, 2024 | 1.09 | 1.12 | 1.07 | 1.07 | 29070.00 |
Nov 11, 2024 | 1.12 | 1.140 | 1.08 | 1.10 | 20341.00 |
Nov 08, 2024 | 1.131 | 1.200 | 1.07 | 1.10 | 26134.00 |
Nov 07, 2024 | 1.14 | 1.20 | 1.14 | 1.15 | 14198.00 |
Nov 06, 2024 | 1.11 | 1.16 | 1.066 | 1.12 | 15246.00 |
Nov 05, 2024 | 1.12 | 1.172 | 1.10 | 1.10 | 11392.00 |
Nov 04, 2024 | 1.15 | 1.18 | 1.05 | 1.110 | 17623.00 |
Nov 01, 2024 | 1.17 | 1.17 | 1.06 | 1.15 | 18272.00 |
Oct 31, 2024 | 1.33 | 1.35 | 1.15 | 1.155 | 81412.00 |
Oct 30, 2024 | 1.33 | 1.36 | 1.32 | 1.33 | 10749.00 |
Oct 29, 2024 | 1.33 | 1.39 | 1.33 | 1.35 | 6772.00 |
Oct 28, 2024 | 1.33 | 1.40 | 1.330 | 1.35 | 41190.00 |
Oct 25, 2024 | 1.30 | 1.345 | 1.29 | 1.31 | 27496.00 |
Oct 24, 2024 | 1.32 | 1.35 | 1.290 | 1.30 | 17543.00 |
Oct 23, 2024 | 1.37 | 1.37 | 1.292 | 1.35 | 26903.00 |
Oct 22, 2024 | 1.41 | 1.42 | 1.34 | 1.34 | 28253.00 |
Oct 21, 2024 | 1.41 | 1.42 | 1.363 | 1.41 | 39917.00 |
Oct 18, 2024 | 1.35 | 1.40 | 1.32 | 1.40 | 36997.00 |
Oct 17, 2024 | 1.32 | 1.365 | 1.29 | 1.32 | 40362.00 |
Oct 16, 2024 | 1.22 | 1.34 | 1.22 | 1.33 | 59126.00 |
Oct 15, 2024 | 1.23 | 1.26 | 1.21 | 1.24 | 32266.00 |
Oct 14, 2024 | 1.30 | 1.31 | 1.24 | 1.24 | 17724.00 |
Oct 11, 2024 | 1.22 | 1.31 | 1.22 | 1.31 | 16083.00 |
Oct 10, 2024 | 1.27 | 1.29 | 1.23 | 1.26 | 25554.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.07
Minimum
Nov 12 2024
263.00
Maximum
Mar 18 2021
60.47
Average
42.20
Median
Oct 10 2022
Price Benchmarks
NovaBay Pharmaceuticals Inc | 0.7125 |
Palatin Technologies Inc | 1.19 |
iBio Inc | 2.32 |
Theriva Biologics Inc | 1.42 |
Oragenics Inc | 0.34 |
Price Related Metrics
Price to Book Value | 0.5785 |
Earnings Yield | -504.7% |
Market Cap | 3.485M |